低危剖宫产患者声门上气道装置与气管插管的比较:系统综述与荟萃分析
首次置入成功率无统计学差异(OR=1.92;95%CI 0.85-4.32;P=.44),置入时间无临床显著差异(WMD=-15.80秒;95%CI -25.30至-6.31秒;P=.001),除声门上气道组咽喉痛减少(OR=0.16;95%CI 0.08-0.32;P<.001)外其他不良事件无差异。分析把握度不足,结论不确定,尚不能推荐声门上气道作为择期剖宫产一线气道。
要点
- 择期剖宫产全麻下声门上气道与气管插管首次成功率无统计学差异。
- 声门上气道置入时间缩短无临床显著意义,咽喉痛发生率更低。
- 证据把握度不足,暂不推荐声门上气道作为择期剖宫产一线气道。
核心结论
- 声门上气道置入成功率与安全性尚可,但分析把握度不足,结论不确定。
- 目前尚不能推荐声门上气道作为择期剖宫产的一线气道。
研究设计与样本
- 系统综述与荟萃分析,检索6个数据库至2019年9月。
- 使用RevMan 5.3软件进行比较荟萃分析。
主要发现
- 首次置入成功率无统计学显著差异(OR=1.92;95%CI 0.85-4.32;I=0%;P=.44)。
- 置入时间无临床显著差异(WMD=-15.80秒;95%CI -25.30至-6.31秒;I=100%;P=.001)。
- 除咽喉痛在声门上气道组减少外(OR=0.16;95%CI 0.08-0.32;I=53%;P<.001),其他不良事件无差异。
临床怎么用
- 择期剖宫产全麻下可考虑声门上气道,但需权衡证据不确定性。
- 声门上气道可能降低咽喉痛发生率,但不足以改变一线气道选择。
局限性
- 分析把握度不足,结论不确定。
- 需要进一步研究才能推荐声门上气道作为择期剖宫产一线气道。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The safety and adverse event rate of supraglottic airway (SGA) devices for cesarean delivery (CD) is poorly characterized. The primary aims of this review were to determine whether the first-pass success was higher and time to insertion for SGA was faster than endotracheal intubation for elective CD. The secondary aim was to determine the airway-related adverse event rate associated with SGA use compared to endotracheal intubation in elective CD under general anesthesia (GA). METHODS: Six databases were systematically searched until September 2019. Included studies reported on the use of SGA in comparison to endotracheal tube intubation. A comparative meta-analysis between SGA and endotracheal intubation was performed using RevMan 5.3 software. Dichotomous outcomes were reported using an odds ratio (OR) with 95% confidence interval (CI). The results for continuous outcomes were reported using a weighted mean difference (WMD) with 95% CI. RESULTS: Fourteen studies with 2236 patients compared SGA and endotracheal intubation. Overall, there was no statistically significant difference in first-attempt success rate (OR = 1.92; 95% CI, 0.85-4.32; I = 0%; P = .44). There was no clinically significant difference in time to insertion (WMD = -15.80 seconds; 95% CI, -25.30 to -6.31 seconds; I= 100%; P = .001). Similarly, there was no difference in any adverse event rate except sore throat which was reduced with the use of an SGA (OR = 0.16; 95% CI, 0.08-0.32; I= 53%; P < .001). CONCLUSIONS: Despite the reasonable insertion success rate and safety profile of SGAs demonstrated in this meta-analysis, the analysis remains underpowered and therefore inconclusive. At present, further studies are required before the use of an SGA as the first-line airway for an elective CD can be recommended.
引用
- White LD, Thang C, Hodsdon A, et al. Comparison of Supraglottic Airway Devices With Endotracheal Intubation in Low-Risk Patients for Cesarean Delivery: Systematic Review and Meta-analysis. Anesth Analg. 2020. PMID: 32925330. doi:10.1213/ANE.0000000000004618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。